Clinical Trials Sponsored by Shenzhen Salubris Pharmaceuticals Co., Ltd. (Salubris)

Total 33 results

Shenzhen Salubris Pharmaceuticals Co., Ltd.

Completed

SAL067 Treatment in Patients With Type 2 Diabetes Who Are Not Controlled by Metformin

Diabetes Mellitus, Type 2

China
Shenzhen Salubris Pharmaceuticals Co., Ltd.

Unknown

Recombinant SeV-hFGF2/dF Injection for PAOD

Critical Limb Ischemia | PAD | PAOD - Peripheral Arterial Occlusive Disease

China
Shenzhen Salubris Pharmaceuticals Co., Ltd.

Unknown

Bivalirudin in Acute Myocardial Infarction

Acute Myocardial Infarction

China
Shenzhen Salubris Pharmaceuticals Co., Ltd.

Recruiting

Sirolimus DEB in Coronary Bifurcation Lesions

Coronary Bifurcation Lesions

China
Shenzhen Salubris Pharmaceuticals Co., Ltd.

Completed

SAL-0951 Tablets in the Treatment of Renal Anemia in Non-dialysis Chronic Kidney Disease

Renal Anemia in Non-dialysis Chronic Kidney Disease

China
Shenzhen Salubris Pharmaceuticals Co., Ltd.

Completed

SAL067 Treatment in Patients With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise

Diabetes Mellitus, Type 2

China
Shenzhen Salubris Pharmaceuticals Co., Ltd.

Completed

Bioequivalence Study of SAL001 and FORSTEO in Healthy Chinese Adults

Postmenopausal Osteoporosis

China
Shenzhen Salubris Pharmaceuticals Co., Ltd.

Unknown

G56W1 in Women With Postmenopausal Osteoporosis

Postmenopausal Osteoporosis

China
Xijing Hospital
Shenzhen Salubris Pharmaceuticals Co., Ltd.

Unknown

Different Dosage of Domestic and Imported Clopidogrel on the Platelet Inhibition Ratio in Patients Undergoing PCI

Coronary Heart Disease
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Changhai Hospital

Recruiting

Evaluating the Safety and Efficacy of the G-stream® Drug-Eluting Stent in the Above-the-Knee Femoropopliteal Artery (G-streamPAD)

Peripheral Artery Disease

China
Shenzhen Kangzhe Pharmaceutical Co., Ltd.

Completed

A Phase Ⅲ Study to Evaluate Tildrakizumab in the Treatment of Chinese Subjects With Moderate to Severe Plaquetype Psoriasis

Plaque Psoriasis

China
Shenzhen Kangzhe Pharmaceutical Co., Ltd.

Unknown

Expanding Phase III Study of Tyroserleutide for Injection

Hepatocellular Carcinoma
Shenzhen Kangzhe Pharmaceutical Co., Ltd.

Unknown

Phase ⅡStudy of Tyroserleutide for Injection in Hepatocellular Carcinoma(HCC) Patients

Hepatocellular Carcinoma

China
Shenzhen Kangzhe Pharmaceutical Co., Ltd.

Unknown

A Study of Oryz-Aspergillus Enzyme and Pancreatin Tablet in Patients With Cirrhosis and Malnutrition

Cirrhosis
MingSight Pharmaceuticals, Inc
Shenzhen MingSight Relin Pharmaceutical Co., Ltd

Recruiting

A Study of MS-553 in Patients With Relapsed or Refractory B-cell Lymphoma

Chronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | Mantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Relapsed or Refractory B-cell Lymphoma | Marginal Zone Lymphoma (MZL)

China
Shenzhen Yangli Pharmaceutical Technology Co., Ltd

Recruiting

Study of TFX06 in Women With Advanced Breast Cancer.

Metastatic Breast Cancer | ER+, HER2- Advanced Breast Cancer

China
Shenzhen Yangli Pharmaceutical Technology Co., Ltd

Recruiting

A Study of TFX05-01 in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
Shenzhen Kexing Pharmaceutical Co., Ltd.

Recruiting

Study Evaluating SHEN26 Capsule in Patients With Mild to Moderate COVID-19

COVID-19

China
Shenzhen Kexing Pharmaceutical Co., Ltd.

Completed

Study of SHEN26 Capsule in Patients With Mild to Moderate COVID-19

COVID-19

China
Shenzhen Kexing Pharmaceutical Co., Ltd.

Recruiting

A Phase I Study of SHEN26 Capsule in Healthy Participants

Healthy Participants

China
Shengzhen Sciprogen Bio-pharmaceutical Co. Ltd

Unknown

A Phase 2 Clinical Study of Pegerythropoietin Injection (RD01) for the Treatment of Anemia in Chronic Renal Failure Patients With Hemodialysis

Patient of Anemia in Chronic Renal Failure With Hemodialysis

China
Shengzhen Sciprogen Bio-pharmaceutical Co. Ltd

Completed

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of RD01 (Pegerythropoietin) in Healthy Chinese Volunteers

Healthy

China
Shenzhen MingSight Relin Pharmaceuticals Co., Ltd.

Recruiting

A Study to Investigate the Efficacy and Safety of MS-553 in CLL/SLL

Small Lymphocytic Lymphoma | Lymphocytic Leukemia

China
Shenzhen MingSight Relin Pharmaceuticals Co., Ltd.
Fountain Medical Development Co., Ltd.

Recruiting

MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema

Diabetic Retinopathy | Diabetic Macular Edema | Macular Edema | Type 2 Diabetes With Diabetic Macular Edema | Type 1 Diabetes With Diabetic Macular Edema

China
Shenzhen Kangzhe Pharmaceutical Co., Ltd.
Fudan University; Medpace, Inc.

Unknown

Study of Tyroserleutide for Injection in Hepatocellular Carcinoma (HCC) Patients

Hepatocellular,Carcinoma

China
Peking University Shenzhen Hospital
Shanghai Shyndec Pharmaceutical Co., Ltd.

Completed

Terconazole Vaginal Suppository vs Fluconazole for the Treatment of Severe Vulvovaginal Candidiasis

Vulvovaginal Candidiasis

China
Harbin Medical University
LanZhou University; Hebei General Hospital; The First Hospital of Jilin University and other collaborators

Active, not recruiting

EROSION II: OCT Guided PPCI in STEMI

ST-segment Elevation Myocardial Infarction

China
Shenzhen Kangzhe Pharmaceutical Co., Ltd.
LanZhou University; Beijing Friendship Hospital; The Third Affiliated Hospital... and other collaborators

Recruiting

A Multicentre Study to Explore the Efficacy and Safety of Mucopolysaccharide Polysulfate Cream in Patients With Eczema

Eczema

China
Chunxiu Gong
The First Affiliated Hospital with Nanjing Medical University; Tongji Hospital and other collaborators

Not yet recruiting

Genetic Diagnosis and Human Growth Hormone Treatment in Small for Gestational Age Children With Short Stature

Genetic Diseases, Inborn | Small for Gestational Age Infant | Silver-Russell Syndrome
Shenzhen Kangzhe Pharmaceutical Co., Ltd.
Hunan Cancer Hospital; Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University and other collaborators

Recruiting

Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection (Lipodox®) in Chinese Patients

Breast Cancer | Ovarian Cancer

China
GeneScience Pharmaceuticals Co., Ltd.
The Second Hospital of Hebei Medical University; Peking University Third Hospital and other collaborators

Unknown

Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency

Growth Hormone Deficiency

China
Peking University Third Hospital
General Hospital of Shenyang Military Region; Xijing Hospital; The First Affiliated... and other collaborators

Completed

Post-Marketing Surveillance of the Cinepazide Maleate Injection: a Real World Study (PACER)

Stroke | Adverse Drug Reaction | Cinepazide

China
Suodi ZHAI
Peking University; The Second Hospital of Hebei Medical University; West China... and other collaborators

Completed

Post-Marketing Surveillance of the Tanreqing Injection: a Real World Study

Adverse Drug Reaction | Drug Allergy

China

Clinical Trials Sponsored by Shenzhen Salubris Pharmaceuticals Co., Ltd. (Salubris)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Turkmenistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations